U.S. Tobacco Stock News

Bakkt (BKKT) just posted its FY 2025 results with third quarter revenue of US$402.2 million and a basic EPS loss of US$1.02, while trailing twelve month revenue sat at US$3.9 billion against a basic EPS loss of US$5.06. Over recent periods, revenue has ranged from US$214.5 million in Q4 2023 to US$1.8 billion in Q4 2024 and US$1.1 billion in Q1 2025, with EPS swinging between a loss of US$7.25 in Q4 2023 and a profit of US$1.18 in Q1 2025. This gives investors a mixed picture on earnings...

Kaltura FY 2025 earnings snapshot Kaltura (KLTR) has just posted its FY 2025 third quarter numbers, reporting revenue of US$43.9 million and a basic EPS loss of US$0.02, alongside net income excluding extra items of a US$2.6 million loss. The company’s recent quarterly revenue has moved from US$45.6 million in Q4 2024 to US$44.5 million in Q2 2025 and US$43.9 million in Q3 2025. Over the same period, basic EPS has ranged between a loss of US$0.07 and a loss of US$0.02. The latest figures...

In its latest quarterly update, Eastman Chemical reported earnings per share above expectations but slightly missed on revenue, highlighted US$60 million of incremental 2025 earnings from its Kingsport methanolysis facility, raised its dividend for the 16th consecutive year, and returned about US$500 million via dividends and buybacks. The company also lifted its 2026 cost reduction target to US$125 million–US$150 million and withheld full-year EPS guidance, underscoring both internal...

Agenus (NasdaqCM:AGEN) has swung to a profit in Q3 FY 2025, reporting total revenue of US$30.2 million and EPS of US$2.00, with net income of US$63.9 million for the period. The company has seen quarterly revenue move from US$23.5 million in Q2 2024 to US$26.8 million in Q4 2024 and then to US$30.2 million in Q3 2025, while EPS shifted from a loss of US$2.52 per share in Q2 2024 to a loss of US$2.00 in Q4 2024 and then to a profit of US$2.00 in Q3 2025, indicating a sharp turn in reported...

American Vanguard (AVD) opened FY 2025 with mixed results, reporting Q3 revenue of US$119.3 million and a basic EPS loss of US$0.43, while on a trailing twelve month basis revenue stood at US$530.1 million alongside a basic EPS loss of US$3.96. The company has seen quarterly revenue move between US$115.8 million and US$165.6 million over the past six reported quarters, with basic EPS losses ranging from US$0.03 to US$3.21. This highlights pressure on profitability even as the top line remains...

FutureFuel (FF) opened FY 2025 with a tough third quarter, reporting revenue of US$22.7 million and a basic EPS loss of US$0.21 alongside a net loss of US$9.3 million, while the trailing twelve months show revenue of US$137.4 million and a basic EPS loss of US$0.79 tied to a net loss of US$34.6 million. Over recent quarters, the company has seen revenue move from US$72.4 million with EPS of US$0.22 in Q2 2024 to US$35.7 million with an EPS loss of US$0.24 in Q2 2025 and then to US$22.7...

Arena Group Holdings (AREN) has just posted its FY 2025 third quarter numbers, with revenue of US$29.8 million and basic EPS of US$0.14, while trailing twelve month revenue came in at US$142.8 million and EPS at US$0.64. Over recent quarters the company has seen revenue move between US$27.2 million and US$45.0 million per period, with basic EPS ranging from a loss of US$0.24 to a profit of US$0.26, and trailing twelve month net income excluding extra items reaching US$30.5 million. For...

HF Foods Group (HFFG) has just posted its FY 2025 third quarter numbers, with revenue at US$307 million and a basic EPS loss of US$0.02, while on a trailing 12 month basis revenue sits at about US$1.23 billion and basic EPS at a loss of US$0.86. The company has seen quarterly revenue move from US$302 million in Q2 FY 2024 to US$307 million in Q3 FY 2025, with basic EPS shifting across that period from roughly breakeven at US$0.00 in Q2 FY 2024 to a loss of US$0.02 in the latest quarter...

TrustCo Bank Corp NY (TRST) has rounded out FY 2025 with fourth quarter revenue of US$47.8 million and basic EPS of US$0.85, backed by trailing twelve month revenue of US$186.3 million and EPS of US$3.26. Over the past year, revenue has moved from US$169.8 million to US$186.3 million on a trailing basis, while basic EPS has shifted from US$2.57 to US$3.26. This sets the scene for investors to focus on how net profit margins at 32.8% and recent earnings growth shape the quality of this...

HUYA (NYSE:HUYA) has posted its latest FY 2025 numbers with Q3 revenue of C¥1.7b and basic EPS of C¥0.04, giving investors an opportunity to reassess the streaming platform's earnings path. The company reported revenue of C¥1.5b in Q1 2025, C¥1.6b in Q2 2025, and C¥1.7b in Q3 2025, while basic EPS moved from C¥0.00 in Q1 to a loss of C¥0.02 in Q2 before returning to a profit of C¥0.04 in Q3. This presents a mixed picture on margins but offers a clearer view of where profitability pressure...

Microvast Holdings (MVST) has posted its latest FY 2025 numbers with Q3 revenue at US$123.3 million, basic EPS at a loss of US$0.00 per share, and net income at a loss of US$1.5 million, while the trailing twelve months show revenue of US$444.5 million and a loss per share of US$0.40. The company has seen quarterly revenue range from US$83.7 million to US$123.3 million over the last six reported periods. Over the same period, basic EPS has swung between a profit of US$0.19 and losses of up to...

Investors wondering if Golar LNG is still reasonably priced after a strong run, or if the easy gains are already behind it, can use this article to focus on what the current share price indicates about value. The stock recently closed at US$44.86, with returns of 3.3% over 30 days, 18.2% year to date and 31.0% over the last year. The past 3 years and 5 years show very large gains of 142.3% and 326.6% respectively. Recent coverage has centered on how Golar LNG is positioned within the energy...

Recent filings show Concorde Financial Corp fully exited its position in Howard Hughes Holdings by selling 52,047 shares, while General Counsel Joseph Valane bought 1,260 shares shortly after the company posted fourth-quarter 2025 results with lower-than-expected EPS but higher-than-expected revenue of US$624.4 million. These opposing moves by an institutional investor and a senior insider come as Howard Hughes pursues a holding-company pivot, faces leverage concerns, and attracts growing...

BioMarin Pharmaceutical (BMRN) is back on investor watch after recent trading left the shares about 20% lower over the past year, despite annual revenue of US$3.2b and net income of US$348.9m. See our latest analysis for BioMarin Pharmaceutical. The recent 1 day share price return of 1.85% decline and 7 day share price return of 5.67% decline sit against a 90 day share price return of 10.93% and a 1 year total shareholder return of 19.73% decline, suggesting short term momentum has softened...

In recent weeks, analysts have raised their earnings forecasts for Strategic Education and upgraded the stock to a Zacks Rank #1 (Strong Buy), signaling higher confidence in its expected financial performance. This broad-based improvement in earnings estimates suggests that analysts are reassessing the company’s underlying business trends rather than reacting to a single, one-off development. We’ll now examine how this stronger analyst earnings outlook may reshape Strategic Education’s...

EyePoint Pharmaceuticals reported fourth-quarter 2025 revenue of US$620,000 versus US$11.59 million a year earlier, with net loss widening to US$67.61 million and basic loss per share from continuing operations rising to US$0.81, while also granting long-term stock options and ending 2025 with cash reportedly sufficient to fund operations into late 2027. Despite weaker financial results, investor attention has shifted toward the CEO’s recent purchase of 1,500 shares, analyst optimism linked...

Wondering if QCR Holdings at around US$82.64 is offering value or asking too much at today's price? This breakdown will help you see what the current market is really pricing in. The stock has seen a 0.9% decline over the last 7 days and a 10.5% decline over the last 30 days, while returns sit at 0.6% year to date and 11.6% over the past year. This gives you a mixed set of signals to weigh. Recent news coverage has focused on QCR Holdings as a regional banking name that investors continue to...

Payoneer Global (NasdaqGM:PAYO) has filed a shelf registration statement for a potential US$79 million offering tied to its Employee Stock Ownership Plan. The filing sets up the ability to issue or sell shares in connection with the ESOP over time, affecting how employee equity is managed. This move adds a fresh element to the Payoneer equity story beyond the recent focus on partnerships and valuation discussion. Payoneer operates a global payments and financial services platform that...

In recent meetings with Global Net Lease’s leadership, Citizens analyst Mitch Germain reaffirmed his view on the company after management outlined progress in cutting leverage from 8.5x at its peak to 6.7x by year-end 2025 through approximately US$3.40 billion of asset sales, alongside an updated capital allocation plan. The company also reported past fourth-quarter 2025 earnings per share of US$0.16, beating analyst expectations despite revenue falling short, indicating that cost controls...

Wondering if Spire's current share price still offers value, or if most of the opportunity is already priced in? This article breaks down what the numbers can and cannot tell you about that question. Spire recently closed at US$92.11, with returns of 0.3% over the past week and month, 10.7% year to date, and 25.7% over the last year, alongside 49.7% over three years and 57.5% over five years. Recent coverage around Spire has focused on its position within the gas utilities space and how...

CytomX Therapeutics earnings and Varseta-M data come into focus CytomX Therapeutics (CTMX) is back on radar after reporting full year 2025 results alongside early Phase 1 expansion data for its EpCAM-targeting ADC, Varseta-M, in late-line metastatic colorectal cancer. See our latest analysis for CytomX Therapeutics. The recent Varseta-M data, full year 2025 results and a new shelf registration plus follow-on equity filing have coincided with sharp share price momentum, with a 1 day share...

Earlier this month, V.F. Corporation presented at Citi’s 2026 Global Consumer & Retail Conference in Aventura, Florida, outlining its latest business updates to investors and industry participants. The event comes amid scrutiny of VF Corp’s shrinking constant-currency revenue, pressured free cash flow margins, and declining return on invested capital, which together highlight ongoing operational headwinds. Next, we’ll examine how these signs of weakening demand and lower returns on invested...

Iron Mountain (NYSE:IRM) has agreed to acquire ACT Logistics in Australia as part of its global expansion. The company continues to grow its data center segment, adding to its traditional records management operations. Iron Mountain recently raised its dividend by 10%, highlighting its focus on shareholder returns. Iron Mountain, best known for records storage and information management, is in the middle of a meaningful shift in where its business is growing. The ACT Logistics deal broadens...

Invesco, NYSE:IVZ, has introduced an employee benefit that supports new U.S. government "Trump Accounts" under Section 530A child savings accounts. The company plans to match the initial government contribution for eligible children of its employees, adding a private employer layer to the federal program. This move links Invesco's employee benefits directly to a current policy initiative focused on long term child savings. For investors tracking NYSE:IVZ, this new benefit sits alongside a...